Inflammatory Bowel Disease Fellowship Program
Houston Methodist is a 900-bed hospital located in the heart of the Texas Medical Center (TMC) — the largest medical complex in the world. Houston Methodist is ranked the No. 1 hospital in Texas for the 12th consecutive year, and No. 5 in Gastroenterology and GI surgery according to U.S. News & World Report. We are excited to start our Inflammatory Bowel Disease Fellowship Program and are actively recruiting for the 2024-2025 academic year.
The Inflammatory Bowel Disease (IBD) Fellowship Program is a 12-month training program with a complement of one-fellow per academic year. The IBD fellow will receive training at the Lynda K. and David M. Underwood Center for Digestive Disorders and the Fondren Inflammatory Bowel Disease Center in the management of patients with Crohn’s disease and ulcerative colitis. The fellow will also have the opportunity to learn intestinal ultrasound for guidance in the immediate treatment decisions and monitoring of patients with IBD. The fellows also will work with gastroenterologists who have received specialized training in IBD, colorectal surgeons, radiologists, research scientists, pathologists and dieticians. Research training will be tailored to meet individual interests and aspirations of each fellow as they receive mentorship and guidance from the program’s core faculty.
Our program’s mission is to develop independent, competent and successful IBD gastroenterologists for entry into either community private practice or an academic environment by providing comprehensive education and training in clinical practice, endoscopic skills, verbal and written communication, and clinical or translational research.
houstonmethodist.org/inflammatory-bowel-disease-fellowship
Houston Methodist Graduate Medical Education
Program Director Kerri Glassner,
Core Faculty Christopher Fan, MD Core Faculty Malcolm Irani, MD Program Coordinator Michelle Henderson 713.441.6081 gastroenterologyfellowship@houstonmethodist.org Associate Program Director Bincy Abraham, MD CONTACT Four Full-time Faculty Members • IBUS Certified in Bowel Ultrasound • Crohn’s and Colitis Foundation IBD Fellowship Trained Fondren Inflammatory Bowel Disease Center O ne Fellow Per Year/ 12 Months Translational Research IBUS Training Center
DO
HOUSTON METHODIST
HOUSTON METHODIST
Houston Methodist is recognized by U.S. News & World Report as the No. 1 hospital in Texas. It has been among “Best Hospitals” for the past 20 years, and on the publication’s Honor Roll consistently. Houston Methodist is affiliated with two of the nation’s leading health-care organizations, Weill Cornell Medicine and NewYork-Presbyterian Hospital. With 2,646 operating beds, 197 operating rooms and more than 29,730 employees, Houston Methodist offers unparalleled care for thousands of patients from around the world.
FONDREN INFLAMMATORY BOWEL DISEASE CENTER
The center’s IBD faculty team is world-renowned for the treatment of gastrointestinal disorders and IBD. Pioneering the use of IUS for IBD patients within the United States, the center is one of the first to offer point-of-case advanced transabdominal ultrasound imaging of the bowel. Our facility also serves as a model 2 IBUS training center for other U.S.-based physicians.
LYNDA K. AND DAVID M. UNDERWOOD CENTER FOR DIGESTIVE DISORDERS
The Underwood Center is one of Houston Methodist’s six centers of excellence — emphasizing medical care, research and academics that are intertwined to enhance patient care and advance the future of health care. Our expansive network of top doctors and specialists, representing a wide spectrum of expertise, collaborate to develop treatments unique to each patient’s needs. The center offers these specialized programs to treat specific digestive disorders and are comprised of nationally and internationally recognized specialists.
RESEARCH
The IBD team’s research explores the interactions between the gut microbiome, its metabolites, and the immune systems to develop targeted therapies for gastrointestinal disorders. Research on immune-mediated diseases of the gastrointestinal tract are ongoing, which includes IBD and immune mediated colitis — a unique form of colitis that has a frequent adverse effect of cancer therapies, such as immune checkpoint inhibitors.
SYSTEM QUICK FACTS
8 Hospitals
7
440,000
1.9M Outpatient visits
138,162 Admissions
20,000
4,500+
29,730 Employees
4,923 Physicians
2,043
814,309
540,000 sq. ft. dedicated research building with 12 stories and 150 lab benches
101,508
772 Faculty
1,430 Clinical protocols
43
268 1,000+
372 Residents and fellows
68 GME programs
ABOUT
HMRI Communications & External Relations | EG | DH | 08.2023
As of January 2023
